Samjin Pharm Total Liabilities

Latest as of September 2025: ₩184.63 Billion KRW ≈ $125.12 Million USD

Samjin Pharm total liabilities. Based on the latest financial reports, Samjin Pharm (005500) has total liabilities worth ₩184.63 Billion KRW (≈ $125.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Samjin Pharm liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Samjin Pharm (2013–2024)

Total liabilities of Samjin Pharm from 2013 to 2024. This chart illustrates how Samjin Pharm's total liabilities have evolved over time, based on quarterly financial data. Explore 005500 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Samjin Pharm Competitors by Total Liabilities

The table below lists competitors of Samjin Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
MEDICLIN Aktiengesellschaft XETRA:MED	Germany	€630.06 Million
Sriracha Construction Public Company Limited BK:SRICHA	Thailand	฿1.58 Billion
Bursa De Valori Bucuresti SA RO:BVB	Romania	RON64.32 Million
ZKH Group Limited NYSE:ZKH	USA	$3.36 Billion
Vina San Pedro SN:VSPT	Chile	CL$153.80 Billion
KJTS KLSE:0293	Malaysia	RM28.47 Million
SCH Group Bhd KLSE:0161	Malaysia	RM740.25 Million
Paloma Acquisition Corp I Class A Ordinary Shares NASDAQ:PALO	USA	$6.85 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Samjin Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Samjin Pharm.

Liquidity & Leverage Metrics

Samjin Pharm Total Liabilities Ratios Explained

Samjin Pharm total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.70	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Samjin Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Samjin Pharm (2013–2024)

The table below shows the annual total liabilities of Samjin Pharm from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩163.51 Billion ≈ $110.81 Million	+5.81%
2023-12-31	₩154.54 Billion ≈ $104.73 Million	+18.24%
2022-12-31	₩130.69 Billion ≈ $88.57 Million	+32.92%
2021-12-31	₩98.33 Billion ≈ $66.64 Million	+76.92%
2020-12-31	₩55.58 Billion ≈ $37.66 Million	+19.07%
2019-12-31	₩46.68 Billion ≈ $31.63 Million	+3.84%
2018-12-31	₩44.95 Billion ≈ $30.46 Million	-7.09%
2017-12-31	₩48.38 Billion ≈ $32.79 Million	-16.41%
2016-12-31	₩57.88 Billion ≈ $39.22 Million	-20.36%
2015-12-31	₩72.67 Billion ≈ $49.25 Million	-12.72%
2014-12-31	₩83.26 Billion ≈ $56.43 Million	-8.46%
2013-12-31	₩90.96 Billion ≈ $61.64 Million	--

About Samjin Pharm

KO:005500 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$169.88 Million

₩250.67 Billion KRW

Market Cap Rank

#16933 Global

#634 in Korea

Share Price

₩20450.00

Change (1 day)

+0.49%

52-Week Range

₩17010.00 - ₩24700.00

All Time High

₩50479.08